Evidence map›Paper›PMID 41777972›Full record

ArticleCureus2026

Ideal Versus Actual Body Weight for Dosage of Sugammadex in Patients With Body Mass Index Less Than 18.5: A Randomized Controlled Trial.

Hanae Sato, Tsukasa Uesaka, Takahiro Suzuki, Hajime Iwasaki

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanae SatoDepartment of Anesthesiology, Nihon University School of Medicine, Tokyo, JPN.
Tsukasa UesakaDepartment of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Asahikawa, JPN.
Takahiro SuzukiDepartment of Anesthesiology, Nihon University School of Medicine, Tokyo, JPN.
Hajime IwasakiDepartment of Anesthesiology, Medical College of Wisconsin, Milwaukee, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo date, no study has evaluated the appropriate sugammadex dose in underweight patients. Therefore, we aimed to compare time to recovery from deep neuromuscular block after administration of sugammadex based on either actual or ideal body weight in patients with a body mass index (BMI) of less than 18.5 kg/m

methodsPatients with a BMI < 18.5 kg/m

resultsA total of 32 patients were included in the analysis. The difference between the actual and ideal body weight groups was not statistically significant (185.6 ± 89.5 s vs 147.3 ± 71.0 s; p = 0.19).

conclusionThere was no significant difference in sugammadex recovery time from deep neuromuscular block between dosing based on actual body weight and dosing based on ideal body weight in underweight patients.

Indexed as

deep neuromuscular blockelectromyographyneuromuscular monitoringsugammadexunderweight patients

Identifiers

PMID41777972
PMCPMC12951408

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.